Literature DB >> 31779821

Classification of atypical parkinsonism per pathology versus phenotype.

Gesine Respondek1, Maria Stamelou2, Günter U Höglinger1.   

Abstract

The umbrella term "atypical parkinsonism" refers to a clinical presentation with various causes, emphasizing the clinical commonality of diseases in which atypical parkinsonism can present. This term is useful for describing the phenomenology of a movement disorder and to classify patients according to their clinical presentation. In contrast to this classification per phenotype, a classification per pathology is needed when it comes to understanding the pathogenesis and designing and delivering disease-modifying therapeutic interventions. Clinico-pathological correlation studies have revealed enormous clinical heterogeneity and vast clinical overlap in pathologically defined diseases related to atypical parkinsonism. Thus, the classification of patients with atypical parkinsonism per phenotype has limited validity for predicting the underlying pathology. This chapter will contrast the phenotype-driven classification and the pathology-driven classification of neurodegenerative diseases related to atypical parkinsonism and discuss future directions to improve pathology-specific diagnosis.
Copyright © 2019 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Atypical parkinsonism; Classification; Clinico-pathological correlation; Pathology; Phenotypes; Tauopathies; α-Synucleinopathies

Mesh:

Year:  2019        PMID: 31779821     DOI: 10.1016/bs.irn.2019.10.003

Source DB:  PubMed          Journal:  Int Rev Neurobiol        ISSN: 0074-7742            Impact factor:   3.230


  4 in total

Review 1.  Lewy body disease or diseases with Lewy bodies?

Authors:  Kateřina Menšíková; Radoslav Matěj; Carlo Colosimo; Raymond Rosales; Lucie Tučková; Jiří Ehrmann; Dominik Hraboš; Kristýna Kolaříková; Radek Vodička; Radek Vrtěl; Martin Procházka; Martin Nevrlý; Michaela Kaiserová; Sandra Kurčová; Pavel Otruba; Petr Kaňovský
Journal:  NPJ Parkinsons Dis       Date:  2022-01-10

Review 2.  Disease modification in Parkinsonism: obstacles and ways forward.

Authors:  M Höllerhage; M Klietz; G U Höglinger
Journal:  J Neural Transm (Vienna)       Date:  2022-06-13       Impact factor: 3.850

3.  Atypical parkinsonism and self-mutilation: A new lens on the old concept.

Authors:  Mehri Salari; Masoud Etemadifar; Kimia Ghanbari
Journal:  Clin Case Rep       Date:  2021-07-09

4.  Blood neurofilament light chain in Parkinson disease and atypical parkinsonisms: A protocol for systematic review and meta-analysis.

Authors:  HongZhou Wang; WanHua Wang; HaiCun Shi; LiJian Han; PingLei Pan
Journal:  Medicine (Baltimore)       Date:  2020-10-02       Impact factor: 1.817

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.